Du C X, Wang Y
Department of Gynecology, The First Affiliated Hospital of He'nan, University of Sience and Technology, Luoyang, China.
Eur J Gynaecol Oncol. 2012;33(3):274-7.
To investigate the expression of P-Akt and NFkappaB and their correlation with human papillomavirus (HPV) infection in cervical carcinoma.
Expression of P-Akt and NFkappaB was detected by an immunohistochemical SP technique with HPV DNA detetion by PCR in 26 cases of cervical carcinoma tissues, 18 cases of cervical intraepithelial neoplasia tissues (CINI / n = 5, CINII / n = 3, CINIII / n = 10) and 19 cases of chronic cervicitis tissues. The different expressions of P-Akt and NFkappaB were compared in different pathological types of cervical carcinoma (cervical squamous cell carcinoma, cervical adenocarcinoma), different pathological grading (high, medium, poorly differentiated) and different clinical stage (FIGO I to IV). The relationships between P-Akt and NFkappaB, respectively, with HPV infection in cervical carcinoma were analyzed.
The positive expression rate of P-Akt in chronic cervicitis tissues, CIN and cervical carcinoma tissues was 21.05%, 66.67%, and 92.31%, respectively. There was no obvious difference in the expression of P-Akt in cervical carcinoma in different pathological types or in pathological grading and no obvious difference in different clinical stages. The positive expression rate of NFkappaB in chronic cervicitis tissues, CIN and cervical carcinoma tissues was 10.52%, 72.22% and 96.15%, respectively; there was no statistically significant difference among the groups for different pathological types and there was no obvious difference in different pathological grading or different clinical stage. There was an obviously positive correlation between P-Akt and NFkappaB expression rate and degree of disease (r = 0.998, p < 0.05). Cervical carcinoma and CIN cases totaled 44; the positive expression rate of P-Akt was 87.55% in 32 cases of positive HPV-DNA of the 44 cases, and the positive expression rate of P-Akt was only 16.70% in 12 cases of negative HPV-DNA of the 44 cases. The positive expression rate of NFkappaB was obviously higher in the HPV DNA positive than in the HPV-DNA negative cases. There was a statistically significant difference among the groups (p < 0.05).
The positive expression rate of P-Akt and NFkappaB was closely related with cervical disease extent, and closely related with HPV infection in cervical carcinoma. This study suggests that P-Akt and NFkappaB more probably play an important role in the occurrence of cervical carcinoma.
探讨P-Akt和NFκB在宫颈癌中的表达及其与人乳头瘤病毒(HPV)感染的相关性。
采用免疫组化SP法检测26例宫颈癌组织、18例宫颈上皮内瘤变组织(CINI / n = 5,CINII / n = 3,CINIII / n = 10)及19例慢性宫颈炎组织中P-Akt和NFκB的表达,同时采用PCR法检测HPV DNA。比较P-Akt和NFκB在不同病理类型(宫颈鳞状细胞癌、宫颈腺癌)、不同病理分级(高分化、中分化、低分化)及不同临床分期(FIGO I至IV期)宫颈癌中的表达差异。分析P-Akt和NFκB分别与宫颈癌中HPV感染的关系。
慢性宫颈炎组织、CIN及宫颈癌组织中P-Akt的阳性表达率分别为21.05%、66.67%和92.31%。P-Akt在不同病理类型、病理分级的宫颈癌组织中的表达无明显差异,在不同临床分期中也无明显差异。慢性宫颈炎组织、CIN及宫颈癌组织中NFκB的阳性表达率分别为10.52%、72.22%和96.15%;不同病理类型组间差异无统计学意义,在不同病理分级及不同临床分期中也无明显差异。P-Akt和NFκB的表达率与病变程度呈明显正相关(r = 0.998,p < 0.05)。宫颈癌及CIN病例共44例;44例中32例HPV-DNA阳性者P-Akt的阳性表达率为87.55%,44例中12例HPV-DNA阴性者P-Akt的阳性表达率仅为16.70%。HPV DNA阳性病例中NFκB的阳性表达率明显高于HPV-DNA阴性病例。组间差异有统计学意义(p < 0.05)。
P-Akt和NFκB的阳性表达率与宫颈病变程度密切相关,且与宫颈癌中的HPV感染密切相关。本研究提示P-Akt和NFκB很可能在宫颈癌的发生中起重要作用。